Aprelieva 150mg Injection

About

Aprelieva 150mg Injection is an antiemetic medication, likely a neurokinin-1 (NK1) receptor antagonist, specifically designed to prevent chemotherapy-induced nausea and vomiting (CINV). It works by blocking the binding of substance P, a neuropeptide, to the NK1 receptors in the brain's vomiting center. This action effectively inhibits both acute and delayed phases of CINV, which are common and distressing side effects of highly emetogenic chemotherapy regimens. The injectable form allows for rapid administration, often given before chemotherapy, to provide prophylactic protection against nausea and vomiting.

Administered intravenously, Aprelieva achieves therapeutic concentrations quickly, offering sustained antiemetic effects. It is typically used in combination with other antiemetics, such as corticosteroids and serotonin 5-HT3 receptor antagonists, to provide comprehensive control of CINV. Due to its specific mechanism of action, it significantly improves patient comfort and adherence to chemotherapy protocols. Careful monitoring for potential drug interactions and adverse effects is essential, especially given the complex medical profiles of oncology patients.

Uses

• Prevention of acute chemotherapy-induced nausea and vomiting (CINV).
• Prevention of delayed CINV.
• Used in combination with other antiemetics for highly emetogenic chemotherapy.
• Prophylaxis against post-operative nausea and vomiting (PONV) in some cases.

Directions For Use

Administer intravenously by a healthcare professional prior to chemotherapy. Follow specific dosing schedules.

Benefits

• Highly effective in preventing CINV.
• Controls both acute and delayed nausea and vomiting.
• Significantly improves patient comfort during chemotherapy.
• Reduces the need for rescue antiemetics.
• Enhances adherence to chemotherapy regimens.
• Provides sustained antiemetic protection.

Side Effects

• Fatigue
• Headache
• Dizziness
• Hiccups
• Constipation
• Diarrhea
• Nausea (despite medication)
• Abdominal pain
• Injection site reactions
• Anorexia
• Weakness
• Elevated liver enzymes

Safety Measures

• Alcohol - No specific contraindication, but alcohol can exacerbate nausea and vomiting, so avoidance is generally advised.
• Pregnancy - Use only if clearly needed and potential benefits outweigh risks; consult a doctor.
• Breastfeeding - Unknown if excreted in breast milk; use with caution or avoid. Consult a doctor.
• Liver - Use with caution in severe liver impairment; monitor liver function.
• Kidney - No dosage adjustment typically required for kidney impairment.
• Lung - Generally safe for use in patients with lung conditions.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.